Article
Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors
Fecha
2018Registro en:
158, , 781-800
02235234
Autor
Reis J.
Cagide F.
Valencia M.E.
Teixeira J.
Bagetta D.
Pérez C.
Uriarte E.
Oliveira P.J.
Ortuso F.
Alcaro S.
Rodríguez-Franco M.I.
Borges F.
Institución
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor
Fernandes C.; Martins C.; Fonseca A.; Nunes R.; Matos M.J.; Silva R.; Garrido J.; Sarmento B.; Remião F.; Otero-Espinar F.J.; Uriarte E.; Borges F. (American Chemical Society, 2018) -
Cholinesterase inhibitors for Alzheimer's disease: Multitargeting strategy based on anti-Alzheimer's drugs repositioning
Kabir M.T.; Uddin M.S.; Begum M.M.; Thangapandiyan S.; Rahman M.S.; Aleya L.; Mathew B.; Ahmed M.; Barreto G.E.; Ashraf G.M. (Bentham Science Publishers, 2019) -
Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: Targeting neurological and mental disorders
Dhiman P.; Malik N.; Sobarzo-Sánchez E.; Uriarte E.; Khatkar A. (MDPI AG, 2019)